Significant variables of different groups | Multivariate analysis | |||
---|---|---|---|---|
Beta | P value | adjusted R2 | VIF | |
LC patients | Â | Â | 0.412 | 1.204 |
 PTSSs | 0.332 | < 0.001 |  |  |
 CRF | 0.247 | 0.02 |  |  |
Subgroup analysis | Â | Â | Â | Â |
Chemotherapy | Â | Â | Â | Â |
Yes | Â | Â | Â | Â |
 DHEA | 0.346 | 0.001 | 0.451 | 1.255 |
 PTSSs | 0.407 | 0.001 |  |  |
 CRF | 0.326 | 0.011 |  |  |
No | Â | Â | Â | Â |
 EQ-VAS | -0.605 | 0.001 |  |  |
Surgery | Â | Â | Â | Â |
Yes | Â | Â | Â | Â |
 DHEA | 0.276 | 0.023 | 0.469 | 1.282 |
No | Â | Â | Â | Â |
 DHEA | 0.322 | 0.022 |  |  |
 CRF | 0.374 | 0.017 |  |  |
Cancer stage | Â | Â | Â | Â |
Early stage (0-II) | Â | No significance | Â | Â |
Advanced stage (III-IV) | Â | Â | Â | Â |
 DHEA | 0.319 | 0.004 | 0.426 | 1.221 |
 PTSSs | 0.396 | 0.001 |  |  |
 CRF | 0.289 | 0.027 |  |  |